SkinBioTherapeutics (SBTX)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

15.13p
   
  • Change Today:
    -1.50p
  • 52 Week High: 26.10p
  • 52 Week Low: 13.88p
  • Currency: UK Pounds
  • Shares Issued: 258.78m
  • Volume: 2,455,839
  • Market Cap: £39.14m

SBTX Overview

SkinBioTherapeutics is a life science company focused on skin health. The Company’s proprietary platform technology, SkinBiotix®, is based upon discoveries made by CSO Dr. Catherine O’Neill and Professor Andrew McBain at The University of Manchester.

Key Personnel

CEO: Stuart Ashman
Executive Director: Simon Hewitson
Independent Non-Executive Director: Catherine Denise Prescott
Non-Executive Chairman: Martin Braddock Hunt
Non-Executive Dir: Danielle Bekker

Contact Details

Address: The Core, Bath Lane, Newcastle Helix, Newcastle upon Tyne, United Kingdom, NE4 5TF
Phone: +44 191 495 7325
Website: http://www.skinbiotherapeutics.com/

Listings

Sector: Pharma and Biotech(LSE)
Index: FTSE AIM All-Share
ISIN: GB00BF33H870

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

SBTX Market Data

Currency UK Pounds
Share Price 15.13p
Change Today -1.50p
% Change -9.02 %
52 Week High 26.10p
52 Week Low 13.88p
Volume 2,455,839
Shares Issued 258.78m
Market Cap £39.14m

SBTX Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
71.12% below the market average71.12% below the market average71.12% below the market average71.12% below the market average71.12% below the market average
75.61% below the sector average75.61% below the sector average75.61% below the sector average75.61% below the sector average75.61% below the sector average
Price Trend
36.07% below the market average36.07% below the market average36.07% below the market average36.07% below the market average36.07% below the market average
9.09% below the sector average9.09% below the sector average9.09% below the sector average9.09% below the sector average9.09% below the sector average
Income Not Available
Growth
49.92% above the market average49.92% above the market average49.92% above the market average49.92% above the market average49.92% above the market average
72.41% above the sector average72.41% above the sector average72.41% above the sector average72.41% above the sector average72.41% above the sector average

SBTX Dividends

No dividends found

Trades for 05-Dec-2025

Time Volume / Share Price
16:16 250,000 @ 15.40p
16:19 12,988 @ 14.91p
16:18 3,381 @ 14.91p
16:17 20,150 @ 14.91p
16:12 20,298 @ 14.80p

SBTX Key Personnel

CEO Stuart Ashman

Top of Page